CRYSTAL ORLOSKY

Physician Assistants & Advanced Practice Nursing Providers|Nurse Practitioner|Family PITTSBURGH, PA NPI 1932948593

General Payments — all program years on this page

$562.06

  • Category: General Payments
  • Program years: PY2024
  • Record count: 38
  • As of (CMS publication): 2026-01-23

Latest program year (PY2024): $562.06 across 38 records · disputed records: 0

Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.

How this figure is calculated
  • The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
  • General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
  • Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
  • Methodology & Data — sourcing, labeling, and limitations.

By nature of payment

Latest program year (PY2024) · sorted by reported total.

Nature of paymentAmountRecords
Food and Beverage $562.0638

By paying entity

Latest program year (PY2024) · sorted by reported total.

By program year

Program yearAmountRecords
2024 $562.0638

Records — PY2024 (38)

Record IDPaying entityAmountDate Nature of paymentDispute statusPublishedSource
1119155211 Otsuka America Pharmaceutical, Inc. $15.27 10/09/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1119155213 Otsuka America Pharmaceutical, Inc. $21.59 12/09/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1147357782 Mylan Specialty L.P. $24.96 05/30/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1147358097 Mylan Specialty L.P. $27.29 09/18/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1150947989 Neurocrine Biosciences, Inc. $26.97 07/15/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1150980762 Neurocrine Biosciences, Inc. $19.81 06/26/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1151007467 Neurocrine Biosciences, Inc. $14.05 12/16/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1151567835 Teva Pharmaceuticals USA, Inc. $15.32 05/20/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1151567837 Teva Pharmaceuticals USA, Inc. $17.88 05/28/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1151567863 Teva Pharmaceuticals USA, Inc. $14.08 06/05/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1151567865 Teva Pharmaceuticals USA, Inc. $13.70 06/18/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1151567881 Teva Pharmaceuticals USA, Inc. $17.32 07/03/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1151567883 Teva Pharmaceuticals USA, Inc. $3.35 07/12/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1151567885 Teva Pharmaceuticals USA, Inc. $15.09 07/12/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1151567887 Teva Pharmaceuticals USA, Inc. $18.05 07/24/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1151567905 Teva Pharmaceuticals USA, Inc. $28.66 08/09/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1151567907 Teva Pharmaceuticals USA, Inc. $14.84 08/13/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1151567909 Teva Pharmaceuticals USA, Inc. $12.19 08/22/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1151567911 Teva Pharmaceuticals USA, Inc. $8.48 08/27/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1151567927 Teva Pharmaceuticals USA, Inc. $1.92 09/03/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1151567929 Teva Pharmaceuticals USA, Inc. $6.77 09/03/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1151567931 Teva Pharmaceuticals USA, Inc. $14.02 09/03/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1151567933 Teva Pharmaceuticals USA, Inc. $20.55 09/11/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1151567935 Teva Pharmaceuticals USA, Inc. $7.13 09/23/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1151567937 Teva Pharmaceuticals USA, Inc. $3.18 09/27/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1151567939 Teva Pharmaceuticals USA, Inc. $15.96 09/27/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1151567951 Teva Pharmaceuticals USA, Inc. $17.80 10/01/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1151567953 Teva Pharmaceuticals USA, Inc. $7.95 10/15/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1151567955 Teva Pharmaceuticals USA, Inc. $10.95 10/15/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1151567957 Teva Pharmaceuticals USA, Inc. $11.16 10/23/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1151567959 Teva Pharmaceuticals USA, Inc. $29.03 10/30/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1151567971 Teva Pharmaceuticals USA, Inc. $7.34 11/08/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1151567973 Teva Pharmaceuticals USA, Inc. $19.76 11/15/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1151567975 Teva Pharmaceuticals USA, Inc. $7.39 11/19/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1151568133 Teva Pharmaceuticals USA, Inc. $6.80 11/26/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1151568151 Teva Pharmaceuticals USA, Inc. $1.78 12/10/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1151568153 Teva Pharmaceuticals USA, Inc. $17.90 12/10/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1151568155 Teva Pharmaceuticals USA, Inc. $25.77 12/19/2024 Food and Beverage Undisputed 01/23/2026 View at CMS

Provenance & corrections

  • Dataset: CMS Open Payments — General Payments
  • Source: CMS Open Payments dataset (bulk file)
  • Publisher of source data: Centers for Medicare & Medicaid Services
  • Generated from: OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv

One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.

Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.